68Ga-tilmanocept

N/A

Report date: 2026/01/21 20:00:47
NME

Base Information

Drug Name68Ga-tilmanocept
Drug Alias Namegallium-68-tilmanocepttilmanocept-[68Ga]CD206 receptor targeting 68Ga-tilmanocept (Navidea)CD206 receptor targeting 68Ga-tilmanocept (Navidea)Gallium 68 labelled tilmanocept
ClassificationSmall molecules > Heterocyclic drugsRadiation-emitting products > Nuclides > Gallium > 68GaRadiation-emitting products > Radioactive diagnostic agent +[4] 
Mechanisms of ActionMacrophage mannose receptor 1 modulators
TargetsMacrophage mannose receptor 1
Therapy Area/IndicationsAtherosclerosisEndometrial NeoplasmsCarcinoma, Endometrioid +[4] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited StatesNetherlands
CombinationsNo
Global Highest StatusPhase 3 Clinical
Highest Status in ChinaN/A
Originator CompaniesNavidea Biopharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesNavidea Biopharmaceuticals IncUmc Utrecht
Inactive CompaniesN/A
Active IndicationsAtherosclerosisEndometrial NeoplasmsCarcinoma, Endometrioid +[4] 
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A